Effectiveness, safety and T-cell activation profiles of long-term Myrcludex B treatment in two patients with HDV related compensated cirrhosis. (February 2019) - Loglio, A.; Alexandrov, A.; Renteria, S.C. Uceda; Tham, C.Y.L.; Greco, L.; Borghi, M.; Perbellini, R.; Trombetta, E.; Giovanelli, S.; Porretti, L.; Lecchi, L.; Prati, D.; et al.